News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Pfizer Inc. (PFE) Drug Reduced Autism Signs in Mice



4/26/2012 7:17:46 AM

An experimental drug for depression being developed by Pfizer Inc. (PFE) (PFE) reduced signs of autism in mice in a study, a finding that may shed light on the cause of the disorder and jump-start research into ways to treat it. The treatment, named GRN-529, targets the brain chemical glutamate, tied to socialization and behavior. When given to mice displaying signs of autism, it suppressed repetitive actions and anti-social behavior, according to the research published today in the journal Science Translational Medicine. Pfizer and the National Institutes of Health funded the study.

Read at BusinessWeek
Read at Philadelphia Inquirer
Read at ABC News


comments powered by Disqus
   
Autism

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES